| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.70B | 44.40B | 27.75B | 27.01B | 20.37B | 6.82B |
| Gross Profit | 5.15B | 6.89B | 4.26B | 2.65B | 2.45B | 254.98M |
| EBITDA | 3.62B | 7.36B | 2.70B | 2.51B | 1.51B | 442.29M |
| Net Income | 808.17M | 1.48B | 591.20M | 294.38M | 691.63M | 140.03M |
Balance Sheet | ||||||
| Total Assets | 130.54B | 148.62B | 122.47B | 105.43B | 90.46B | 38.62B |
| Cash, Cash Equivalents and Short-Term Investments | 11.25B | 12.20B | 10.89B | 7.98B | 11.11B | 9.29B |
| Total Debt | 52.53B | 72.30B | 46.22B | 29.25B | 17.82B | 2.92B |
| Total Liabilities | 81.73B | 95.14B | 74.42B | 59.04B | 48.89B | 13.63B |
| Stockholders Equity | 35.65B | 36.75B | 35.18B | 34.65B | 34.38B | 29.56B |
Cash Flow | ||||||
| Free Cash Flow | -10.74B | -6.64B | -13.49B | -17.23B | -33.50B | -11.13B |
| Operating Cash Flow | 2.47B | 7.38B | 3.11B | 2.90B | 3.28B | 2.01B |
| Investing Cash Flow | -15.04B | -17.92B | -18.28B | -19.93B | -24.00B | -15.01B |
| Financing Cash Flow | 6.15B | 10.24B | 16.39B | 13.90B | 29.76B | 14.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$26.89B | 6.29 | 17.75% | 2.24% | 15.73% | 49.88% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | HK$1.29B | 12.35 | 19.99% | ― | 11.61% | 287.50% | |
54 Neutral | HK$52.57B | ― | 1.78% | ― | 60.41% | 150.51% | |
52 Neutral | HK$1.41B | -2.34 | -3.73% | 6.40% | -34.79% | -130.42% | |
51 Neutral | HK$455.61M | -1.78 | -16.83% | ― | -15.04% | 71.02% | |
43 Neutral | HK$190.98M | -18.54 | -6.19% | ― | 5.07% | 28.18% |